Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

RWDD3 Antikörper

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch RWDD3 in ELISA und IHC. Er zeigt eine Reaktivität gegenüber Human.
Produktnummer ABIN7118740

Kurzübersicht für RWDD3 Antikörper (ABIN7118740)

Target

Alle RWDD3 Antikörper anzeigen
RWDD3 (RWD Domain Containing 3 (RWDD3))

Reaktivität

  • 17
  • 8
  • 7
  • 2
  • 1
Human

Wirt

  • 16
  • 1
Kaninchen

Klonalität

  • 17
Polyklonal

Konjugat

  • 12
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser RWDD3 Antikörper ist unkonjugiert

Applikation

  • 17
  • 11
  • 9
  • 7
  • 2
  • 2
ELISA, Immunohistochemistry (IHC)
  • Aufreinigung

    Immunogen affinity purified

    Reinheit

    ≥95 % as determined by SDS-PAGE

    Immunogen

    RWD domain containing 3

    Isotyp

    IgG
  • Applikationshinweise

    IHC: 1:20-1:200

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Buffer

    PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    -20°C for 12 months (Avoid repeated freeze / thaw cycles.)

    Haltbarkeit

    12 months
  • Target

    RWDD3 (RWD Domain Containing 3 (RWDD3))

    Andere Bezeichnung

    RWDD3

    Hintergrund

    Synonyms:RSUME Background:Enhancer of SUMO conjugation. Via its interaction with UBE2I/UBC9, increases SUMO conjugation to proteins by promoting the binding of E1 and E2 enzymes, thioester linkage between SUMO and UBE2I/UBC9 and transfer of SUMO to specific target proteins which include HIF1A, PIAS, NFKBIA, NR3C1 and TOP1. Isoform 1 and isoform 2 positively regulate the NF-kappa-B signaling pathway by enhancing the sumoylation of NF-kappa-B inhibitor alpha(NFKBIA), promoting its stabilization which consequently leads to an increased inhibition of NF-kappa-B transcriptional activity. Isoform 1 and isoform 2 negatively regulate the hypoxia-inducible factor-1 alpha(HIF1A) signaling pathway by increasing the sumoylation of HIF1A, promoting its stabilization, transcriptional activity and the expression of its target gene VEGFA during hypoxia. Isoform 2 promotes the sumoylation and transcriptional activity of the glucocorticoid receptor NR3C1 and enhances the interaction of SUMO1 and NR3C1 with UBE2I/UBC9. Has no effect on ubiquitination.

    Gen-ID

    25950

    UniProt

    Q9Y3V2
Sie sind hier:
Chat with us!